William Howland
Allergy & Immunology · Austin, TXNPI 1770550535
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (43.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Optinose US, Inc. at 46.1% of the total. Reporting peaked in 2019 at $4,975 and has fallen 65.3% since, to $1,724 in 2025.
Across 92 payments — averaging $92.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$4K
- Novartis$2K
- AstraZeneca$1K
- Sanofi$573
- Regeneron Healthcare Solutions, Inc.$402
- Amgen$195
- plus $691 from 12 others
Across 713 payments — averaging $4971.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$919K
- AbbVie$737K
- Sanofi US Services Inc.$609K
- AstraZeneca$387K
- Teva Pharmaceuticals USA, Inc.$257K
- Hikma Pharmaceuticals USA$238K
- plus $398K from 8 others
What the payments were for
- Speaking & faculty fees$3,55042%
- Travel & lodging$1,18614%
- Food & beverage$3,64943%
- Education$821%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 6 | $3,905 |
| Novartis | 7 | $1,587 |
| AstraZeneca | 33 | $1,114 |
| Sanofi | 8 | $573 |
| Regeneron Healthcare Solutions, Inc. | 13 | $402 |
| Amgen | 2 | $195 |
| Galderma Laboratories, L.p. | 1 | $136 |
| AbbVie | 1 | $126 |
| GSK | 4 | $96 |
| Alk-abello, Inc | 5 | $96 |
| Boehringer Ingelheim | 2 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $49 |
| Teva Pharmaceuticals USA, Inc. | 3 | $44 |
| Mylan Specialty L.p. | 1 | $24 |
| Kaleo, Inc. | 1 | $20 |
| Eyevance Pharmaceuticals LLC | 1 | $17 |
| Genentech USA, Inc. | 1 | $17 |
| Circassia Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,467 in reported general payments places this provider in the 60th percentile of 336 allergy & immunology providers in Texas.
Other allergy & immunology in Austin
- Paul VigoAustin$304K
- Neha ReshamwalaAustin$303K
- Michael VolzAustin$78K
- Allen LiebermanAustin$39K
- Stacy SilversAustin$26K
- Ojas PatelAustin$23K
- Joseph DiazSan Antonio$1.1M
- Richard WassermanDallas$452K
- Matthew FeldmanDallas$410K
- Lukena KarkhanisSan Antonio$377K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.